咨询内容:What do you do for a living? http://femjoy.in.net/ femjoy.com "The body of evidence for Revlimid in myeloma includesthousands of patients in clinical studies, has never revealedany death imbalance in any myeloma setting and regardless ofcombination use with any other agent," Brean Capital analystGene Mack said in a research note.